Mizuho Maintains Outperform on Boston Scientific, Lowers Price Target to $70

Benzinga · 1d ago
Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $90 to $70.